To determine whether estradiol-to-progesterone (E2/P) ratios at the time of embryo …

• Abstract
• Background
• Patients and methods
• Results
• Discussion
• Conclusion
• References
• Figure
• Tables

1. Edwards RG, Steptoe PC, Purdy JM: Establishing full-term pregnancies using cleaving embryos grown in vitro.

   Br J Obstet Gynaecol 1980, 87:737-756.

2. Smitz J, Devroey P, Camus M, Deschacht J, Khan I, Staessen C, Van Waesberghe L, Wisanto A, Van Steirteghem AC: The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT.

   Hum Reprod 1988, 3:585-590.

3. Albano C, Grimbizis G, Smitz J, Riethmuller-Winzen H, Reissmann T, Van Steirteghem A, Devroey P: The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotrophin-realising hormone antagonist Cetrorelix.

   Fertil Steril 1998, 70:357-359.

4. Forman R, Fries N, Testart J, Belaisch-Allart J, Hazout A, Frydman R: Evidence for an adverse effect of elevated serum estradiol concentrations on embryo implantation.

   Fertil Steril 1988, 49:118-122.

5. Sharara FI, McClamrock HD: Ratio of estradiol concentration on the day of human chorionic gonadotrophin administration to mid-luteal estradiol concentration is predictive of in-vitro fertilization outcome.

   Hum Reprod 1999, 14:2777-2782.

6. Ng Hung Yu E, Shu Biu Yeung W, Yee Lan Lau E, Wai Ki So W, Ho Chung P: A rapid decline in serum oestradiol concentrations around the mid-luteal phase had no adverse effect on outcome in 763 assisted reproduction cycles.

   Hum Reprod 2000, 15:1903-1908.

7. Csapo AI, Pulkkinen MO, Weist NG: Effects of luteectomy and progesterone replacement therapy in early pregnant patients.

   Am J Obstet Gynecol 1973, 115:759-765.

8. Csapo A, Pulkkinen MO, Kaihola HL: The effect of estradiol replacement therapy on early pregnant luteectomized patients.

   Am J Obstet Gynecol 1973, 115:987-990.

9. Weitlauf HM: Biology of implantation.In The Physiology of Reproduction. New York: Raven Press; 1994:233-277.

10. Devroey P, van Steirteghem A: A review of ten years experience of ICSI.

    Hum Reprod Update 2004, 10:19-28.

11. Zegers-Hochschild F, Nygren KG, Adamson D, de Mouzon J, Lancaster P, Mansour R, Sullivan E: The International Committee Monitoring Assisted Reproductive Technologies (ICMART) glossary on ART terminology.

    Fertil Steril 2006, 86:16-19.

12. Gore BZ, Cadwell BV, Speroff L: Estrogen-induced human luteolysis.

    J Clin Endocrinol Metab 1973, 36:615-617.

13. Lessey BA, Killam AP, Metzger DA, Haney AF, Greene GL, McCarty KS: Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle.

    J Clin Endocrinol Metab 1988, 67:34-340.

14. Garcia E, Bouchard P, De Brux J, Berdah J, Frydman R, Perrot-Applanat M: Use of immunocytochemistra of progesterone and estrogen receptors for endometrial dating.

    J Clin Endocrinol Metab 1988, 67:80-87.

15. Paulson RJ, Sauer MV, Lobo RA: Embryo implantation after human in vitro fertilization: importance of endometrial receptivity.

    Fertil Steril 1990, 53:870-874.

16. Gardner DK, Schoolcraft WB, Wagley L, Schlenker T, Stevens John , Hesla J: A prospective randomized trial of blastocyst culture and transfer in in-vitro fertilization.

    Hum Reprod 1998, 13:3434-3440.

17. Lopata A: Molecular aspects of implantation. Blastocyst-endometrial interaction: an appraisal of some old and new ideas.

    Mol Hum Reprod 1996, 2:519-525.

18. Macklon NS, Fauser BC: Impact of ovarian hyperstimulation on the luteal phase.

    J Reprod Fertil 2000, (Suppl 55):101-108.

19. Beckers NG, Laven JS, Eijkemans MJ, Fauser BC: Folicular and luteal phase characteristics following early cessation of gonadotropin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization.

    Hum Reprod 2000, 15:43-49.

20. Clayton RN, Catt KJ: Regulation of pituitary gonadotropin-releasing hormone receptors by gonadal hormones.

    Endocrinology 1981, 108:887-895.

21. Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, Bustion S, Loumaye E, Fauser BC: Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist co treatment.

    J Clin Endocrinol Metab 2003, 88:4186-4192.

22. Papanikolaou EG, Bourgain C, Kolibianakis E, Tournaye H, Devroey P: Steroid recepter expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already transformation in the absence of secretory changes.

    Hum Reprod 2005, 20:1541-1547.

23. Friedler S, Gilboa S, Schachter M, Raziel A, Strassburger D, Ron ELR: Luteal phase characteristics following GnRH antagonist or agonist treatment – a comparative study.

    Reprod Biomed Online 2006, 12:27-32.